Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
13,022
+1,683
+15% +$190K 0.65% 65
2025
Q4
$1.42M Buy
11,339
+1,291
+13% +$164K 0.52% 58
2025
Q3
$1.35M Buy
10,048
+461
+5% +$60.5K 0.49% 91
2025
Q2
$1.3M Buy
+9,587
New +$1.26M 0.49% 117
2025
Q1
Sell
-1,650
Closed -$187K 48
2024
Q4
$187K Buy
+1,650
New +$191K 0.12% 68

Other funds holding ABT

Stance Capital's ABT Position: Q1 2026 in Review

Stance Capital increased its Abbott (ABT) stake by 15% in Q1 2026, buying an estimated $190K and bringing the position to 13,022 shares worth $1.34M. The position accounts for 0.65% of the portfolio, ranked #65.

Stance Capital first reported a position in ABT in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.42M in Q4 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Stance Capital held 13,022 shares of Abbott worth $1.34M as of Q1 2026.
  • Stance Capital bought 1,683 Abbott shares in Q1 2026, an estimated $190K.
  • Abbott made up 0.65% of Stance Capital's portfolio in Q1 2026, its #65 holding.
  • Stance Capital first reported a position in Abbott in Q4 2024 and has held it in 5 quarters since.
  • Stance Capital's Abbott position peaked at $1.42M in Q4 2025.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.